AVTE logo

Aerovate Therapeutics (AVTE) Company Overview

Profile

Full Name:

Aerovate Therapeutics, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

June 30, 2021

Indexes:

Not included

Description:

Aerovate Therapeutics (AVTE) is a biotechnology company focused on developing innovative treatments for respiratory diseases. They aim to improve patient outcomes by creating advanced therapies that target specific conditions, enhancing the quality of life for those affected by lung-related illnesses.

Events Calendar

Earnings

Next earnings date:

Mar 25, 2025

Recent quarterly earnings:

Nov 12, 2024

Recent annual earnings:

Mar 25, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Jun 18, 24 Wells Fargo
Equal-Weight
Jun 18, 24 TD Cowen
Hold
Jun 18, 24 Guggenheim
Neutral
Jun 18, 24 Evercore ISI Group
In-Line
Jun 17, 24 Jefferies
Hold
Jun 17, 24 BTIG
Neutral
Jun 6, 24 Wedbush
Outperform
May 22, 24 Wedbush
Outperform
May 14, 24 Wedbush
Outperform
Apr 1, 24 Wells Fargo
Overweight

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Aerovate Therapeutics?
  • Does Aerovate Therapeutics pay dividends?
  • What sector is Aerovate Therapeutics in?
  • What industry is Aerovate Therapeutics in?
  • What country is Aerovate Therapeutics based in?
  • When did Aerovate Therapeutics go public?
  • Is Aerovate Therapeutics in the S&P 500?
  • Is Aerovate Therapeutics in the NASDAQ 100?
  • Is Aerovate Therapeutics in the Dow Jones?
  • When was Aerovate Therapeutics's last earnings report?
  • When does Aerovate Therapeutics report earnings?
  • Should I buy Aerovate Therapeutics stock now?

What is the ticker symbol for Aerovate Therapeutics?

The ticker symbol for Aerovate Therapeutics is NASDAQ:AVTE

Does Aerovate Therapeutics pay dividends?

No, Aerovate Therapeutics does not pay dividends

What sector is Aerovate Therapeutics in?

Aerovate Therapeutics is in the Healthcare sector

What industry is Aerovate Therapeutics in?

Aerovate Therapeutics is in the Biotechnology industry

What country is Aerovate Therapeutics based in?

Aerovate Therapeutics is headquartered in United States

When did Aerovate Therapeutics go public?

Aerovate Therapeutics's initial public offering (IPO) was on June 30, 2021

Is Aerovate Therapeutics in the S&P 500?

No, Aerovate Therapeutics is not included in the S&P 500 index

Is Aerovate Therapeutics in the NASDAQ 100?

No, Aerovate Therapeutics is not included in the NASDAQ 100 index

Is Aerovate Therapeutics in the Dow Jones?

No, Aerovate Therapeutics is not included in the Dow Jones index

When was Aerovate Therapeutics's last earnings report?

Aerovate Therapeutics's most recent earnings report was on Nov 12, 2024

When does Aerovate Therapeutics report earnings?

The next expected earnings date for Aerovate Therapeutics is Mar 25, 2025

Should I buy Aerovate Therapeutics stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions